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The enzymatic pathways for formation of 1,2-diradylglyceride in response to 
epidermal growth factor in human dermal fibroblasts have been investigated. 
1,2-Diradylglyceride mass was elevated 2-fold within one minute of addition of 
EGF. Maximal accumulation (4-fold) occurred at 5 minutes. Since both diacyl and 
ether-linked diglyceride species occur naturally and may accumulate following 
agonist activation, we developed a novel method to determine separately the 
alterations in diacyl and ether-linked diglycerides following stimulation of 
fibroblasts with EGF. Utilizing this method, it was found that approximately 80% 
of the total cellular 1,2-diradylglyceride was diacyl, the remaining 20% being 
ether-linked. Addition of EGF caused accumulation of 1,2-diacyIglyceride with- 
out alteration in the level of ether-linked diglyceride. Thus, the observed 
induction of 1,2-diradylglyceride by EGF was due exclusively to increased 
tormation of 1,2-diacylglyceride. In cells labelled with [ 'Hlcholine, the water 
soluble phosphatidylcholine hydrolysis products, phosphorylcholine and 
choline, were increased 2-fold within 5 minutes of addition of EGF. No hydrolysis 
ot phosphatidylethanolamine, phosphatidylserine, or phosphatidylinositol was 
observed. Quantitation by radiolabel and mass revealed equivalent elevations in 
phosphorylcholine and choline, suggesting stimulation of both phospholipase C 
and phospholipase D activities. To identify the presence of ECF-induced phos- 
pholipase D activity, cells were labelled with exogenous ['HI 1 -0-hexadecyl, 
2-acyl phosphatidylcholine and its conversion to phosphatidic acid in response to 
EGF determined. Radiolabelled phosphatidic acid was detectable in 15 seconds 
after addition of EGF and was maximal (3-fold) at 30 seconds. Consistent with the 
presence of EGF-induced phospholipase D activity, treatment of cells with EGF, 
in the presence of ['3Clethanol, resulted in the rapid formation of 
["C]phosphatidylethanol, the product of phospholipase D-catalyzed transphos- 
phatidylation. The formation of phosphatidylethanol, which competes for the 
formation of phosphatidic acid by phospholipase D, did not diminish the 
induction of 1,2-diglyceride by EGF. These data suggest that the phosphatidic acid 
formed by phospholipase D-catalyzed hydrolysis of phosphatidylcholine is  not a 
major precursor of the observed increased 1 ,z-diglyceride. Thus, the induction of 
1,2-diacylglycerol by EGF may occur primarily via phospholipase C-catalyzed 
hydrolysis of phosphatidylcholine. 
Ce l lu la r  1,2-diradylglycerides are composed of a het -  
erogeneous m i x t u r e  o f  molecular species, containing 
carbon side chains of varying lengths and degrees of 
unsatura t ion  l i n k e d  by an ester bond t o  the  sn-2 
position, and by e i ther  an ester (diacyl) o r  ether (ether- 
l inked)  bond t o  the  sn-1 posi t ion of glycerol. Recent 
interest  in 1,2-diradylglycerides has  focused o n  t h e i r  
ro le as second messengers involved in transducing 
extracel lu lar  signals across t h e  ce l l  surface membrane. 
1,2-Diacylglycerol i s  t h e  physiological act ivator of pro- 
te in  k inase C, w h i c h  i s  involved in the  regu la t ion  of a 
diverse number  of ce l lu la r  funct ions (Berr idge e t  al., 
1985; H a n n u n  and Bel l ,  1987). Under  appropriate in 
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v i t ro  conditions, naturally occurr ing e ther - l inked di- 
glycerides are also able t o  act ivate p ro te in  k inase C 
(Ford e t  al., 19891, a l though whether  they  do so in v i vo  
i s  n o t  known.  Agonist- induced accumulat ion of 1,2- 
diradylglycerides may ar ise f r o m  phospholipase-cata- 
lyzed breakdown of bo th  d iacy l  and ether- l inked species 
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of phosphatidylinositol, phosphatidylcholine, or phos- 
phatidylethanolamine (Rider et al., 1988; Kiss and 
Anderson, 1989; Price et al., 1989; Matozaki and 
Williams, 1989). Hydrolysis of these phospholipids by 
phospholipase C directly yields 1,2-diradylglycerides. 
Alternatively, 1,2-diradylglycerides may be generated 
by the combined actions of phospholipase D and phos- 
phatidic acid phosphohydrolyase (Cabot et al., 1988; 
Bocckino et al., 1987a; Nishijima et al., 1989). 1,2- 
diradylglyceride levels in agonist-stimulated cells may 
also be elevated as a result of de novo synthesis (Farese 
et al., 1987). Thus there are complex multiple pathways 
leading to enhanced formation of 1,2-diradylglycerides 
in agonist-stimulated cells. In view of the important 
regulatory role of 1,2-diradylglycerides, the enzymatic 
pathways that regulate their formation are of great 
interest. 
Epidermal rowth factor (EGF) is a potent polypep- 
tide mitogen f or a wide variety of cell types, including 
human dermal fibroblasts. The actions of EGF are 
primarily mediated through its specific cell surface 
receptor. The EGF receptor possesses intrinsic tyrosine 
kinase activity, which is stimulated by EGF and re- 
quired for biological responses to EGF (reviewed in 
Schlessinger, 1988; Gill et al., 1988). Evidence suggests 
that activation of the EGF receptor results in rapid 
stimulation of membrane phospholipid turnover, pre- 
sumably through modulation of phospholipase activi- 
ties (Wright et al., 1988). Phosphoinositide-specific 
phospholipase C-r has been demonstrated to associate 
with the EGF receptor and to be phosphorylated by the 
EGF receptor tyrosine kinase, although the functional 
consequences of this are not clear (Wahl et al., 1989; 
Nishibe et al., 1989). In transformed human epithelial 
cell lines, which overexpress EGF receptors, EGF stim- 
ulates phospholipase C-catalyzed phosphoinositide 
turnover, elevates 1,2-diglyceride content, and acti- 
vates protein kinase C (Hirai and Shimizu, 1989; Pike 
and Eakes, 1987; Wahl and Carpenter, 1988). In IIC9 
hamster embryo fibroblasts, EGF does not stimulate 
phosphoinositide breakdown, but does stimulate phos- 
phatidylcholine hydrolysis and accumulation of 1,2- 
diradylglyceride (Wright et al., 1988). These data sug- 
gest that EGF may influence the formation of 1,2- 
diradylglyceride via several different mechanisms. 
To delineate those mechanisms through which EGF 
regulates 1,2-diglyceride formation in human dermal 
fibroblasts, we have investigated the kinetics, phospho- 
lipid sources, and enzymatic pathways for the forma- 
tion of 1,2-diacyl and ether-linked glycerides. The data 
indicate that: 1) EGF stimulates accumulation of 1,2- 
diacylglyceride, but not ether-linked diglycerides, 2) 
EGF-induced 1,2-diacylglyceride is formed from phos- 
phatidylcholine not phosphatidylethanolamine, phos- 
phatidylserine, or phosphatidylinositol, 3) EGF stimu- 
lates phospholipase D-catalyzed formation of 
phosphatidic acid and phosphatidylethanol from phos- 
phatidylcholine and 4) the major route for EGF-induced 
1,2-diacylglyceride formation appears not to be via 
phospholipase D, but presumably via phospholipase 
C-catalyzed phosphatidylcholine hydrolysis. 
MATERIALS AND METHODS 
T2P]ATP, ["]acetic anhydride, [3H2choline, [3Hlinosi- 
tol. PHlethanolamine. 13H Iserine. r 4Clethanol. r3Hl- 
0-hexadecyl, 2-hydroxy phosphatidylcholine, and 
[ 3Hlglycerol were obtained from New England Nuclear 
(Boston, MA). Purified mouse salivary gland EGF was 
a generous gift of Daniel Rabin, Johns Hopkins Uni- 
versity. Choline, phosphorylcholine, phospholipase C 
from B. Cereus, 1-0-hexadecyl, 2-oleoyl phosphatidyl- 
choline, choline kinase, and alkaline phosphatase were 
from Sigma Chemical Co. (St. Louis, MO). Phospholip- 
ids and 1,2-dioleoylglycerol were from Avanti Biochem- 
icals (Alabaster, ALL Bovine ethanolamine plasmalo- 
gen was from Serdary (Port Huron, MI). All other 
chemicals were of at least reagent grade. 
Cells and cell culture 
Human dermal fibroblasts were cultured from kera- 
tome biopsies of adult human skin. Dermis was sepa- 
rated from epidermis by trypsinization (0.25% trypsin, 
0.1% EDTA) of the tissue for 30 minutes at  37°C in 
phosphate buffered saline. Once separated the dermis 
was cut into small pieces (4mm on each side) and placed 
in a lOOmm dish in a minimal amount of media 
(McCoy's modified 5A containing 10% fetal bovine 
serum) to prevent the tissue from floating. The tissue 
was removed after one week, at which time cells were 
observed to have migrated out of the tissue. When these 
primary cultures were confluent they were expanded 
by passage. Cells were used for experiments between 
passages 3 and 6 .  
Metabolic labelling of dermal fibroblasts 
Subconfluent cultures in 100mm dishes were placed 
in serum free media and labelled with L3H1choline 
(5kCi/ml), r3H1ethanolamine (5&i/ml), ['Hlserine 
(5~Ci/ml), or [3Hlinositol (5pCiiml) for two days or with 
13Hlflycerol (1mCiiml) for two hours. For incorporation 
of I' C lethanol into phosphatidylethanol, [14C]ethanol 
(2pCi/ml) was added to cells 5 minutes prior to addition 
of EGF. With the exception of inositol, cells were 
labelled in McCoy's modified 5A media containing 
5 g/ml bovine serum albumin. Cells were labelled with 
[&linositol in inositol free Delbecco's modified Eagle's 
medium. To measure the conversion of phosphatidyl- 
choline to phosphatidic acid cells were incubated with 
[3H11-O-hexadecyl, 2-hydroxy phosphatidylcholine 
(lpCi/ml) for two hours. Following this, cells were 
washed to remove unincorporated label, placed in fresh 
serum free media, and treated with EGF for the indi- 
cated times. 
Treatment of cells and analysis of labelled 
metabolites 
Cultures in serum free media were washed with fresh 
media and incubated at 37°C for 20 minutes. Cultures 
were then given fresh media with or without EGF 
(50ngiml) and incubated for the times indicated in the 
text. Incubations were terminated by addition of ice 
cold methanol (2ml), following aspiration of the media 
and washing with 2ml phosphate buffered saline (PBS). 
The cells were scraped from the dish, and the dish was 
washed with an additional 2ml methanol. The com- 
bined methanol fractions were extracted according to 
the method of Bligh and Dyer (1959). The chloroform 
and aqueous phases were separated and dried under 
nitrogen and vacuum, respectively. To analyze incor- 
poration of radioactivitv into endonenous DhosDholiDids 
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the chloroform fraction was subjected to thin layer 
chromatography (silica gel 60) in chloroform: metha- 
nol: 20% methylamine (60:36: 10). Metabolism of exog- 
enous 13H]1-0-hexadecyl, 2-hydroxy phosphatidylcho- 
line was analyzed by thin layer chromatography 
developed in ch1oroform:methanol:acetic acid (65:30:4). 
Incorporation of [3Hlethanol into phosphatidylethanol, 
was determined by thin layer chromatography of the 
chloroform extract in iso-0ctane:ethylacetate:acetic 
acid:water (110:50:20:100~ iPai et al., 1988). Spots were 
visualized by iodine vapor, identified by co-chromatog- 
raphy with standards, scraped, and counted. [3H]Inosi- 
to1 phosphates in the aqueous fraction were analyzed by 
Dowex ion exchange chromatography as previously 
described (Downes et al., 1982). Water soluble metab- 
olites of [3H]ethanolamine and [3Hlcholine were resus- 
pended in 50% methanol and analyzed by thin layer 
chromatography according to the methods of Lacal 
et al. (1987) and Yavin (19851, respectively. 
Measurement of choline and phosphorylcholine 
content and choline kinase activity 
Choline and phosphorylcholine content was deter- 
mined by modifications of the procedures described by 
Haubrich et al. (1981) and McCaman and Stetzler 
(1977). Briefly, the aqueous cellular extract from four 
lOOmm dishes was divided into two aliquots and dried 
under vacuum. For the measurement of choline, one 
aliquot, was redissolved in buffer containing 6 x lo5 
cpm [32P]ATP (0.35 mM) and 20 unitslml choline 
kinase. The mixture was incubated at  37°C for one hour 
and then lOOmM phosphorylcholine was added as 
carrier. [32PlPhosphorylcholine was quantitated by 
counting following separation from ["PIATP by Dowex 
chromatography. For the measurement of phosphoryl- 
choline plus choline, the remaining aliquot was dis- 
solved in buffer a t  pH 9.2 and treated with alkaline 
phosphatase (5 units) at 37°C for four hours to  convert 
phosphorylcholine to choline. Following this, alkaline 
phosphatase was inactivated by boiling the sample for 
15 minutes. The pH of the reaction mixture was 
adjusted to 7.0 with Tris maleate (2OOmh4, pH 6.0) and 
choline determined as described above. The amount of 
phosphorylcholine in the original sample was calcu- 
lated as the difference between the values for choline 
obtained with and without pretreatment of the sample 
with alkaline phosphatase. 
For the measurement of choline kinase activity, cells 
in serum-free media were treated with EGF (50ngiml) 
for the times indicated in the text and collected by 
scraping in 50mM tris (pH 8.0). The cells were lysed by 
brief sonication and a high speed supernatant prepared 
by contrifugation (100,000 x g for one hour). Choline 
kinase activity in the supernatant was assayed as 
described (Weinhold and Rethy, 1974). 
Measurement of 172-diradylglyceride 
Dermal fibroblasts were treated with EGF (50ng/ml) 
at 37°C for the times indicated in the text. Incubations 
were terminated by addition of ice cold methanol. 
1,2-Diradylglycerides were extracted with chloroform 
and quantified by conversion to [32P]phosphatidic acid 
with E. coli diglyceride kinase, according to the proce- 
dure of Preiss et al. (1987). 
Measurement of 172-diacyl- and 1-alkyl, 
2-acyl-diglyceride 
Alterations in the amounts of 1,2-diacyl and 1-ether, 
2-acyl-glycerides in dermal fibroblasts following treat- 
ment with EGF were determined by conversion of 
1,2-diradylglycerides to radiolabelled 3-acetate deriva- 
tives with l3H1acetic anhydride and resolution of the 
diacyl and ether-linked derivatives by thin layer chro- 
matography (Renkonen, 1966). 1,2-Diradylglycerides 
were extracted from fibroblast cultures as described 
above and purified by thin layer chromatography on 
silica gel 60 developed in benzene:chloroform:methanol 
(80: 15:5). Cellular 1,2-diradylglycerides and standards 
were dried under a stream of nitrogen and dissolved in 
3 0 ~ 1  benzene containin 2 5 ~  dimethlyaminopyridine. 
To each sample, 25kCi [ Hlacetic anhydride (10~1) and 
100pmol unlabeled acetic anhydride (10~1) were added. 
This was allowed to react for 20 hours at 25°C. Meth- 
anol (250~1) was added to destroy excess acetic anhy- 
dride and the r3H]diglyceride derivatives extracted by 
addition of 7 5 0 ~ 1  chloroform/H20 (2: 1 ). The chloroform 
extracts were dried and spotted on silica gel 60 TLC 
plates (Whatman LK6), which were developed in tolu- 
ene:ether (96:4). 1,2-diacylglycerol acetate (Rf 0.281, 
1-alkyl, 2-acyl glycerol acetate (Rf 0.41) and 1-alk-enyl, 
2-acyl glycerol acetate (&. 0.54) were visualized by 
iodine vapor, identified by comparison to standards, 
scraped, and counted. The standards utilized were 
1,2-dioleoylglycerol, 1-0-hexadecyl, 2-oleoylglycerol, 
and 1-alk-enyl, 2-acyl glycerol. The later two were 
prepared by phospholipase C (B. Cereus) digestion of 
the corresponding synthetic choline and bovine etha- 
nolamine plasmalogen phospholipids, respectively 
(Conn et al., 1986). 
RESULTS 
Time course of EGF-stimulated 
1,2-diradylglyceride formation 
Addition of EGF (50nglml) to serum starved human 
dermal fibroblasts resulted in a rapid increase in 
1,2-diradylglyceride. l,2-Diradylglyceride was maxi- 
mally elevated (3-fold) within five minutes and re- 
mained elevated for a t  least 120 minutes (Fig. 1). 
Similar kinetics for EGF-stimulated diglyceride pro- 
duction have been observed in Chinese hamster embryo 
fibroblasts (Wright et al., 1988). 
Analysis of EGF-induced changes in diacyl and 
ether-linked diglycerides 
Recent studies have demonstrated that both 1,2- 
diacyl and ether-linked diglycerides are present in 
biological membranes and may accumulate following 
agonist activation (Rider et al., 1988; Tyagi et al, 1989). 
We therefore wanted to determine separately the 
changes in diacyl and ether-linked diglycerides follow- 
ing stimulation of dermal fibroblasts with EGF. Since 
the enzymatic assay utilized above (Fig. 1) to quantify 
1,2-diradylglyceride content does not distinguish be- 
tween 1,2-diacyl and ether-linked diglycerides (Rider et 
al., 1988), it was necessary to develop a method to 
separately quantitate these two diglyceride classes. 
This was accomplished by converting the 1,2-diradyl- 
glycerides to L3H]acetate derivatives and resolving the 
1,2-diacyl and ether-linked diglyceride acetates by thin 
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Fig. 1. Stimulation of 1,2-diradylglyceride by EGF. Human dermal 
fibroblasts were cultured in the absence of serum for two days and 
placed in serum free media with (0) or without ( 0 )  EGF (50ngiml) for 
the indicated times. 1,2-diradylglyceride content was determined as 
described in Materials and Methods. Data points are the means 2 S.D. 
of duplicate determinations from three experiments. 
layer chromatography. Utilizing this method, measure- 
ment of both diacyl and ether-linked diglyceride ace- 
tates was linear between 0.1 and 2.0nmol (Fig. 2). 
In unstimulated fibroblasts, approximately 20% of 
the total 1,2-diradylglyceride was ether-linked (1-0- 
alkyl, 2-acyl and 1-0-alk-enyl, 2-acyl diglycerides were 
combined for analysis). Figure 3 demonstrates that the 
levels of 1,2-diacylglyceride were significantly elevated 
following addition of EGF. The kinetics and magnitude 
of change of 1,2-diacylglycerol (Fig. 3) were essentially 
identical to those observed for total 1,2-diradylglyc- 
eride (Fig. 1). In contrast, no change in the level of 
ether-linked diglycerides was observed in response to 
EGF. These data demonstrate that the observed in- 
creases in 1,2-diglyceride following EGF stimulation 
are due solely to elevations in 1,2-diacylglycerol con- 
tent. 
Effect of EGF on de novo synthesis of 
1,a-diglyceride 
To determine whether EGF stimulates de novo syn- 
thesis of 1,2-diradylglyceride, serum starved dermal 
fibroblasts were labelled with [3Hlglycerol and treated 
with or without EGF (50ngirnl) for five or 120 minutes, 
and radioactivity in 1,2-diradylglyceride was mea- 
sured. At five minutes, EGF failed to stimulate incor- 
poration of label into 1,2-diradylglyceride (747 & 201 
cpm control, 823 k 165 plus EGF, n=3). Treatment of 
cells for 120 minutes with EGF resulted in a 4.8-fold 
elevation of label in 1,2-diradylglyceride (873 2 230 
cpm control, 4261 +- 309 cpm plus EGF, n=3). These 
data indicate that the observed elevations in 1,2- 
diacylglycerol that occur within 5 minutes of EGF 
addition are not due to de novo synthesis. At 120 
minutes, however, de novo synthesis may contribute to 
the observed accumulation of 1,2-diacylglycerol in re- 
sponse to  EGF. 
Effect of EGF of phospholipid headgroup 
turnover 
Hydrolysis of inositol, choline and ethanolamine 
containing phospholipids have all been reported to 
contribute to 1,2-digIyceride formation. We therefore 
investigated the effect of EGF on the hydrolysis of 
different phospholipid headgroup classes in human 
dermal fibroblasts. Serum deprived cells were incu- 
bated with either [3H]choline, L3Hlethano1amine, 
[3H]serine, or [3Hlinositol for 48 hours to metabolically 
label phosphatidylcholine, phosphatidylethanolamine, 
phosphatidylserine, or phosphatidylinositol, respec- 
tively. Labelled cells were then exposed to EGF (50ngi 
ml) for five minutes and radioactivity in the phospho- 
lipids and water soluble intracellular metabolites 
quantitated. 
Each of the labelled precursors was readily taken up 
by the fibroblasts and incorporated predominantly 
(greater than 90%) into phospholipid. Analysis of cel- 
lular phospholipids by thin layer chromatography re- 
vealed that each of the radioactive precursors was 
incorporated almost exclusively into the expected phos- 
pholipid headgroup class (data not shown). 
Addition of EGF caused a marked increase in total 
intracellular water soluble radioactivity in choline 
labelled cells (Table 1). In contrast, no changes in 
intracellular soluble radioactivity were detected fol- 
lowing stimulation with EGF of cells labelled with 
ethanolamine, serine, or inositol. These data suggest 
that hydrolysis of phosphatidylcholine is enhanced by 
EGF. 
Time course of EGF-induced 
phosphatidylcholine hydrolysis 
We next determined the kinetics of accumulation of 
choline metabolites in response to EGF. Cells were 
labelled with L3H1choline, stimulated with EGF for 
various times and intracellular radioactive water sol- 
uble products analyzed by thin layer chromatography. 
In unstimulated cells, approximately 80% of the intra- 
cellular soluble radioactivity was found in phosphoryl- 
choline, and choline, in a ratio of 55% to 45%. The 
remainder of the label was approximately equally 
distributed among acetylcholine, glycerophosphoryl- 
choline, and CDP-choline. Following addition of EGF 
(50ng/ml), total intracellular soluble radioactivity was 
maximally increased (2-fold) within five to fifteen 
minutes and remained above baseline (1.5-fold eleva- 
tion) for up to 120 minutes. Analysis of water soluble 
radioactivity by thin layer chromatography revealed 
approximately equal elevations (2-fold) in choline and 
phosphorylcholine. Radioactivity in the other choline 
metabolites was not altered by addition of EGF (data 
not shown). 
Truett et al. (1989) have reported that the level of 
phosphorylcholine in stimulated neutrophils deter- 
mined by labeling with C3H1choline is significantly 
lower than the mass amount determined by enzymatic 
assay. This presumably reflects non-uniform labeling 
of cellular phosphatidylcholine. Whether EGF-induced 
changes in radiolabelled choline and phosphorylcholine 
is an accurate measure of alterations in the masses of 
these compounds, in dermal fibroblasts, is not known. 
We therefore measured changes in mass of choline and 
phosphorylcholine in response to EGF (Fig. 4). Choline 
increased from 3.7nmo1/106 cells to 5.7nmo1/106 cells 
within five minutes after addition of EGF. The amount 
of choline remained maximally elevated between 5 and 
15 minutes and then gradually declined over 120 
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Fig. 2. Quantitative determination of 1,2-diacylglycerol acetate. The 
indicated amounts of 1,2-dioleoylglycerol were acylated with 
I'Hlacetic anhydride and separated by TLC as described in Materials 
and Methods. The appropriate spots were scraped from the plate and 
counted. 
minutes. Phosphorylcholine increased with kinetics 
similar to choline, reaching a maximum between 5 and 
15 minutes followed by a decline to 50% of maximum 
over 120 minutes. These data on changes in mass of 
choline and phosphorylcholine are in good agreement 
with the data presented above on changes in radiola- 
belled choline and phosphorylcholine. 
Growth factors, including EGF (Warden and Fried- 
kin, 19841, and oncogenic transformation (Macara, 
1989) have been reported to induce choline kinase 
activity in 3T3 fibroblasts. If EGF were to rapidly 
induce choline kinase activity, this could partially 
contribute to the observed elevations in phosphorylcho- 
line following stimulation of dermal fibroblasts with 
EGF. To investigate this possibility, choline kinase 
activity was assayed in cells following exposure to EGF 
for 0,5, and 180 minutes. Treatment with EGF for five 
minutes did not alter choline kinase activity, compared 
to control (control, 0.6920.31; EGF, 0.7620.25 nmoli 
min/mg; n=4). A small increase in choline kinase 
activity was seen following 180 minutes exposure to 
EGF (1.2 nmol/min/mg). These data indicate that in- 
duction of choline kinase activity does not contribute to 
the increased phosphorylcholine content, that occurs 
within 5 minutes following EGF treatment. 
EGF-stimulated formation of phosphatidic acid 
The kinetics of phosphatidylcholine turnover as  de- 
termined by accumulation of choline and phosphoryl- 
choline (Fig. 4) are similar to those observed for forma- 
tion of 1,2-diacylglycerol (Fig. 2). This suggests that 
EGF-stimulated 1,2-diacylglycerol formation may re- 
sult from activation of phospholipase C and/or phospho- 
lipase D-catalyzed hydrolysis of phosphatidylcholine. 
Pai et al. (1988) have demonstrated agonist activa- 
tion of phospholipase D activity in HL-60 cells by 
assessing the conversion of synthetic ether-linked phos- 
phatidylcholine, bearing radiolabel in both the phos- 
phate (32P) and 1-0-alkyl chain (3H), to phosphatidic 
acid. We have employed a similar procedure to assess 
whether EGF stimulates phospholipase D activity in 
human dermal fibroblasts. Cells were incubated with 
Fig. 3. Time course of EGF-induced alterations in 1,Zdiacyl and 
1-ether, 2-acyl glycerides. Serum deprived dermal fibroblasts were 
incubated in serum free media with (0)  or without ( 0 )  EGF (50ng/ml) 
for the indicated times. Lipids were extracted and 1,2-diacyl and 
ether-linked diglycerides quantitated as described in Materials and 
Methods. Results are the means of duplicate determinations from two 
experiments. 
TABLE 1. EGF-induced release of phospholipid head groups' 
Control EGF 
Choline 8056 * 485 14,075 f 1158 
Serine 8954 * 723 9107 + 682 
E thanolamine 45,265 f 4806 41,004 f 4371 
Inositol 21,631 f 798 16,473 + 863 
phosphates 
'Fibroblasts were labelled for two days in serum free media with SpiCi/ml of the 
indicated tritiated compounds. EGF (50ngIml) was added for five minutes and 
intracellular water soluble metabolites analyzed a s  described in Materials and 
Methods. Results are means * S.D. of duplicate determinations from three 
experiments. 
[3H11-O-hexadecyl-lysophosphatidylcholine (the dou- 
ble-labelled phospholipid was not available to us), 
treated with EGF for various times, and the radioactive 
lipids formed analyzed by thin layer chromatography. 
Following 2 hour incubation, greater than 906 of the 
[3H11-O-hexadecyl-lysophosphatidylcholine taken up 
by the cells was esterified to phosphatidylcholine. 
Addition of EGF to the cells resulted in the rapid 
appearance of [3Hlphosphatidic acid (Fig. 5). Increased 
phosphatidic acid was detectable within 15 seconds and 
was maximal (3-fold) a t  30 seconds, after addition of 
EGF. The level of [3Hlphosphatidic acid returned to 
baseline within 20 minutes. This may have resulted 
from dephosphorylation to diglyceride, dealkylation to 
lyso-phosphatidic acid or reacylation to phospholipid. 
No accumulation of radioactivity in the neutral lipid 
fraction, was observed, suggesting that re-esterifica- 
tion to phospholipid may account for the decline in 
labelled phosphatidic acid. Some metabolism via either 
dephosphorylation or dealkylation, however, cannot be 
ruled out. 
These data suggest that EGF stimulates phospholi- 
pase D-catalyzed hydrolysis of phosphatidylcholine. 
Although phosphatidic acid may also be formed from 
phosphatidylcholine by the combined actions of phos- 
pholipase C and phos hatidate phosphohydrolyase, the rapid appearance of I Y Hlphosphatidic acid and the lack 
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Fig. 4. Time course of EGF-induced accumulation of choline and 
phosphorylcholine. Dermal fibroblasts in serum free media were 
incubated in the presence (0, A) or absence (0, A) of EGF (50ngiml) for 
the indicated times. The cells were scraped from the dish, extracted 
and choline (A, A) and phosphorylcholine (o,.) content determined as 
described in Materials and Methods. The data points are means of 
duplicate determinations from two or three experiments. Error bars 
(?  S.D.) are shown for points from three experiments. 
of accumulation of label in the neutral lipid fraction 
suggest that the majority of the observed increase in 
[3H]phosphatidic acid in response to EGF is due to  
activation of phospholipase D. 
Effect of ethanol on EGF-stimulated 
1,a-diglyceride formation 
In the presence of ethanol, phospholipase D-catalyzed 
hydrolysis of phosphatidylcholine results in transphos- 
phatidylation of phosphatidylcholine to phosphati- 
dylethanol. Transphosphatidylation of exogenous alco- 
hol into phosphatidylcholine has been shown to be a 
reliable measure of agonist-induced phospholipase D 
activity (Bocckino et al., 1987b; Billah et al., 1989a; 
Randall et al., 1990). To further substantiate the 
presence of EGF-stimulated phospholipase D activity 
in dermal fibroblasts, cells were treated with 0.5% 
[14C]ethanol for five minutes prior to addition of EGF 
(at time 0) for five minutes, and the amount of 
['4Clphosphatidylethanol determined. Analysis of cel- 
lular phospholipids by thin layer chromatography re- 
vealed that EGF significantly stimulated formation of 
[14Clphosphatidylethanol within five minutes. A small 
increase over background in formation of [l4C1phos- 
phatidylethanol was also observed when the 
[l4C1ethanol was added for 10 minutes, 110 minutes 
after addition of EGF (Fig. 6A). These data indicate 
that phospholipase D activity in human dermal fibro- 
blasts is stimulated within minutes of addition of EGF, 
and remains elevated for two hours. 
To assess the relative contribution of phospholipase 
D activation to EGF-induced accumulation of 1,2- 
diglyceride, the effect of ethanol on 1,2-diglyceride 
formation was determined. If the phosphatidic acid 
formed from hydrolysis of phosphatidylcholine by phos- 
pholipase D is a major precursor for 1,2-diglyceride 
formation, than diversion of phosphatidic acid to phos- 
phatidylethanol should result in diminished accumu- 
lation of 1,2-diglyceride. This has been shown to occur 
5 
0 '  
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Fig. 5. EGF-induced formation of phosphatidic acid. Serum deprived 
dermal fibroblasts were incubated with [3HJ1-O-hexadecyl, 2-hydroxy 
phosphatidylcholine (0.5~Ciiml) for 2 hours. The cells were washed to 
remove unincorporated radioactivity and incubated in serum free 
media with EGF (50ngiml) for the indicated times. Cellular phospho- 
lipids were extracted and analyzed by TLC as described in Materials 
and Methods. In the absence of EGF, no change in the amount of 
[3Hlphosphatidic acid was observed during the course of the experi- 
ment (data not shown). Results are the means i S.D. of duplicate 
determinations from three experiments. 
in f-met-leu-phe-stimulated human neutrophils (Billah 
et al., 1989b). 
As expected, EGF alone induced a 3-fold increase in 
1,2-diglyceride content within five minutes (Fig. 6B). 
Treatment of cells with ethanol five minutes prior to 
addition of EGF for five minutes, under identical 
conditions shown to result in phosphatidylethanol for- 
mation (Fig. 6A), had no significant effect on EGF- 
induced formation of 1,2-diglyceride (Fig. 6B). Simi- 
larly, ethanol added for 10 minutes, 110 minutes after 
treatment of cells with EGF, was without effect on the 
increased 1,2-diglyceride observed at 120 minutes after 
addition of EGF. These data suggest that although EGF 
rapidly stimulates phospholipase D activity, the phos- 
phatidic formed may not be a major source of 1,2- 
diglyceride formed in response to EGF in human der- 
mal fibroblasts. 
DISCUSSION 
The above data demonstrate that EGF stimulates 
rapid and sustained accumulation of 1,2-diacylglycerol. 
Although 20% of the total 1,2-diglyceride in quiescent 
cells was ether-linked, no increase in ether-linked 
diglycerides was detected following stimulation with 
EGF. Pessin and Raben (1989) also found in IIC9 cells 
that the l12-diglyceride induced by &-thrombin was 
entirely diacyl. Kennerly (1987) also has observed that 
activation of mast cells by IgE receptor cross-linking 
resulted in accumulation of only 1,2-diacylglycerides. 
In contrast, significant elevations in both diacyl and 
ether-linked diglycerides have been reported to occur in 
TPA-primed human neutrophils stimulated with 
f-met-leu-phe (Rider et al., 1988). 
Although EGF has been demonstrated to stimulate 
phosphoinositide turnover in A-431 cells and other 
transformed cell types, it did not in normal human 
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Fig. 6. Effect of ethanol on EGF-stimulated phosphatidylethanol and 
1,2-diglyceride formation. A: Serum deprived dermal fibroblasts were 
incubated in serum free media with @ 1 or without (01 EGF (50ngl 
ml). [14ClEthanol (0 .54)  was added 5 minutes prior to EGF (left bars) 
or 110 minutes after addition of EGF (right bars). At the indicated 
times cellular phospholipids were extracted and [14C]phosphatidyl- 
dermal fibroblasts. Similarly, EGF did not stimulate 
phosphatid lethanolamine turnover as has been re- 
son, 1989). Wright et al. (1988) were also unable to 
detect EGF-stimulated phosphatidylinositol or phos- 
phatidylethanolamine hydrolysis in hamster embryo 
fibroblasts. 
In contrast, EGF caused significant elevations in 
water soluble metabolites of phosphatidylcholine. Both 
choline and phosphorylcholine, but not CDP-choline or 
acetylcholine, increased rapidly following exposure of 
dermal fibroblasts to EGF. These data are consistent 
with EGF stimulating breakdown of phosphatidylcho- 
line via activation of phospholipase C and/or phospho- 
lipase D. The kinetics of accumulation of choline, 
phosphorylcholine and 1,2-diacylglyceride were simi- 
lar, suggesting that increased amounts of 1,2-diacyl- 
glyceride arise through EGF-stimulated hydrolysis of 
phosphatidylcholine. 
EGF markedly stimulated phospholipase D-cata- 
lyzed transphosphatidylation of ethanol into phospho- 
lipid within five minutes. This did not, however, reduce 
EGF-induced formation of 1,2-diglyceride. This is in 
contrast to studies in human neutrophils, in which 
ethanol, at the concentration employed in our study, 
significantly inhibited 1,2-diglyceride formation 
(Billah et al., 1989b). Assuming that the transphos- 
phatidylation reaction catalyzed by phospholipase D in 
human dermal fibroblasts occurs to the same extent as 
that observed in human neutrophils, the lack of effect 
of EGF-induced phosphatidylethanol formation on 
EGF-induced 1,2-diglyceride accumulation suggests 
that the phosphatidic acid that is formed by the action 
of phos holipase D is not a major source of 1,2-diglyc- 
phosphatidylcholine hydrolysis may be the predomi- 
nant pathway for formation of 1,2-diacylglycerol in 
EGF-stimulated dermal fibroblasts. The observed in- 
crease in phosphorylcholine following EGF treatment 
ported for i! PA in several cell types (Kiss and Ander- 





I EGF plun n O H  
0 CONlROL - 
0 Es c m o L  plus ETW 









5 min 120 rnin 
ethanol determined as described in Materials and Methods. B: Dermal 
fibroblasts were treated with ID .M 1 or without 0.m I EGF as in A in 
the presence I 0 5 I or absence 0) of 0.56 ethanol. Cellular lipids 
were extracted and analyzed for l,%diglyceride content as described 
in Materials and Methods. Results are the means 2 S.D. of duplicate 
determinations from three experiments. 
is consistent with the activation of this pathway, 
although it does not provide direct roof, since phos- 
kinase. Choline kinase activity was detected in human 
dermal fibroblasts, however, EGF treatment for five 
minutes did not alter its activity. The elevations in 
phosphorylcholine content, which were observed 
within five minutes of EGF stimulation, are therefore 
not due to increased choline kinase activity. Several 
studies have inferred from indirect evidence that ago- 
nist-induced 1,2-diglyceride formation occurs primarily 
through phospholipase C-catalyzed phosphatidylcho- 
line hydrolysis (Besterman et al., 1986; Diaz-Meco et 
al., 1989; Larrodera et al., 1990). 
In contrast, studies using hepatocytes (Bocckino et 
al., 1987a), neutrophils (Billah et al., 1989b) and 
REF52 cells (Cabot et al., 1988) have concluded that 
agonist-induced formation of 1,2-diglyceride from phos- 
phatidylcholine occurs through sequential activation of 
phospholipase D and phosphatidate phosphohydrol- 
yase. This conclusion is based on preferential accumu- 
lation of choline over phosphorylcholine, the kinetics of 
formation of phosphatidic acid and 1,2-diacylglycerol 
and inhibition of 1,2-diglyceride formation by the phos- 
phatidate phosphohydrolyase inhibitor propranolol. 
Much of these data, however, have been obtained using 
the active phorbol ester TPA as an agonist and may 
therefore reflect mechanisms different from those elic- 
ited by physiological agonists such as EGF. TPA, 
unlike physiological agonists, directly activates protein 
kinase C, bypassing 1,2-diacylglyceride formation. 
Thus TPA-induced activation of phospholipase D and 
1,2-diacylglyceride formation may be a consequence of 
protein kinase C activation. Physiological agonists, 
conversely, stimulate phospholipid hydrolysis, result- 
ing in formation of 1,2-diglyceride, prior to activation of 
protein kinase C. Thus the mechanisms through which 
TPA and physiological agonists stimulate 1,2-diglyc- 
eride formation may differ. Vasopressin, however, sim- 
phorylcholine may be formed from c K oline by choline 
3 16 FISHER ET AL. 
ilar to TPA, has been reported t o  induce formation of 
1,2-diglyceride in hepatocytes through activation of 
phospholipase D (Bocckino et al., 1987a). Thus depend- 
ing on the cell type and agonist, l,2-diglyceride may be 
generated from phosphatidylcholine by either phospho- 
lipase C or phospholipase D. 
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